Published in J Hypertens on January 01, 2014
Hypertension in Long-Term Care Facilities | NCT03046420
Uncontrolled Hypertension Management (TEAM-HTN) (TEAM-HTN) | NCT03281772
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial. J Am Soc Hypertens (2015) 2.11
Updated national and international hypertension guidelines: a review of current recommendations. Drugs (2014) 1.41
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol (2014) 1.08
Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review. Ann Intern Med (2015) 0.97
Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc (2015) 0.93
Commentary on the 2014 BP guidelines from the panel appointed to the Eighth Joint National Committee (JNC 8). J Am Soc Nephrol (2014) 0.88
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study. Hypertension (2015) 0.87
Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction. Hypertens Res (2015) 0.86
Chinese Hypertension Guidelines. Pulse (Basel) (2015) 0.84
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring. Drugs R D (2014) 0.84
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results. J Hypertens (2014) 0.83
Accurate quantitative measurements of brachial artery cross-sectional vascular area and vascular volume elastic modulus using automated oscillometric measurements: comparison with brachial artery ultrasound. Hypertens Res (2015) 0.83
Clinician's guide to the updated ABCs of cardiovascular disease prevention. J Am Heart Assoc (2014) 0.82
Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? J Am Heart Assoc (2015) 0.82
US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future. J Am Heart Assoc (2015) 0.82
South African hypertension practice guideline 2014. Cardiovasc J Afr (2015) 0.82
Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response. Curr Opin Pharmacol (2016) 0.81
Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. J Hum Hypertens (2016) 0.79
Hypertension Prevalence, Awareness and Blood Pressure Control in Matao, Brazil: A Pilot Study in Partnership With the Brazilian Family Health Strategy Program. J Clin Med Res (2016) 0.79
Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Hypertension (2014) 0.79
Is 60 the New 80 in Hypertension? J Gen Intern Med (2016) 0.79
Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens (2015) 0.79
Effects of a community-based salt reduction program in a regional Australian population. BMC Public Health (2016) 0.79
Developmental trajectories of adiposity from birth until early adulthood and association with cardiometabolic risk factors. Int J Obes (Lond) (2015) 0.78
The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults. Curr Hypertens Rep (2015) 0.78
Thirty-Minute Office Blood Pressure Monitoring in Primary Care. Ann Fam Med (2017) 0.77
Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study. Patient Prefer Adherence (2014) 0.77
Current and Future Treatment of Hypertension in the SPRINT Era. Methodist Debakey Cardiovasc J (2016) 0.77
Is amlodipine more cardioprotective than other antihypertensive drug classes? Korean J Intern Med (2014) 0.77
How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional Study. PLoS One (2016) 0.77
Recent advances in understanding hypertension development in sub-Saharan Africa. J Hum Hypertens (2017) 0.77
Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis. J Hum Hypertens (2016) 0.76
Serum Soluble Corin Deficiency Predicts Major Disability within 3 Months after Acute Stroke. PLoS One (2016) 0.76
Amlodipine/valsartan single pill combination therapy in Chinese patients not controlled on previous monotherapy. J Thorac Dis (2015) 0.76
Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study. Hypertension (2016) 0.76
Anti-hypertensive Herbs and their Mechanisms of Action: Part I. Front Pharmacol (2016) 0.76
Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens (2016) 0.76
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure. Cardiol Ther (2015) 0.75
Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication. Circ Cardiovasc Qual Outcomes (2016) 0.75
Authors' reply. J Postgrad Med (2015) 0.75
Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes. Integr Blood Press Control (2015) 0.75
What should the blood pressure treatment goal be in adults with hypertension in 2016? Ann Transl Med (2016) 0.75
Rate of change in renal function and mortality in elderly treated hypertensive patients. Clin J Am Soc Nephrol (2015) 0.75
Identifying the optimal blood pressure target for ideal health. J Transl Int Med (2016) 0.75
Dietary and lifestyle factors in hypertension. J Hum Hypertens (2016) 0.75
Prevalence of hypertension and its treatment among adults presenting to primary health clinics in rural Zambia: analysis of an observational database. BMC Public Health (2015) 0.75
Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ (2017) 0.75
Relationship Between Blood Pressure Values, Depressive Symptoms, and Cardiovascular Outcomes in Patients With Cardiometabolic Disease. J Clin Hypertens (Greenwich) (2016) 0.75
Refractory Hypotension as an Initial Presentation of Bilateral Subclavian Artery Stenosis. Case Rep Cardiol (2016) 0.75
Improved Blood Pressure Control Using an Interactive Mobile Phone Support System. J Clin Hypertens (Greenwich) (2015) 0.75
Regarding hypertension treatment are we following worldwide tendencies? Arq Bras Cardiol (2014) 0.75
Tobacco use pattern among a national firefighter cohort. Nicotine Tob Res (2014) 0.75
Sodium and Its Role in Cardiovascular Disease - The Debate Continues. Front Endocrinol (Lausanne) (2016) 0.75
Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses. J Clin Pharmacol (2016) 0.75
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response. Circ Cardiovasc Genet (2017) 0.75
Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults. BMJ Open (2015) 0.75
Towards prevention of hypertension in Nigeria: a study of prehypertension and its associations among apparently healthy adults in Umuahia, South-East Nigeria. Int J Prev Med (2015) 0.75
Arterial Stiffness: Recommendations and Standardization. Pulse (Basel) (2016) 0.75
A practical approach to the pharmacological management of hypertension in older people. Ther Adv Drug Saf (2016) 0.75
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity. Medicine (Baltimore) (2015) 0.75
Hypertension management in rural primary care facilities in Zambia: a mixed methods study. BMC Health Serv Res (2017) 0.75
Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study. BMJ Open Diabetes Res Care (2016) 0.75
Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension. J Hum Hypertens (2015) 0.75
Brachial-ankle pulse wave velocity is associated with coronary calcification among 1131 healthy middle-aged men. Int J Cardiol (2015) 0.75
Hypertension Guidelines: Timely New Initiatives from East Asia. Pulse (Basel) (2015) 0.75
Trajectories of total and central adiposity throughout adolescence and cardiometabolic factors in early adulthood. Int J Obes (Lond) (2016) 0.75
Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial. J Hum Hypertens (2016) 0.75
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. Am J Cardiovasc Drugs (2016) 0.75
Exercise for Multimorbid Patients in Primary Care: One Prescription for All? Sports Med (2017) 0.75
Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus. J Am Heart Assoc (2017) 0.75
Association of Husband Smoking With Wife's Hypertension Status in Over 5 Million Chinese Females Aged 20 to 49 Years. J Am Heart Assoc (2017) 0.75
Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai. Aging Dis (2017) 0.75
Duration and degree of adiposity: Effect on cardiovascular risk factors at early adulthood. Int J Obes (Lond) (2017) 0.75
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med (2017) 0.75
The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension. Acta Cardiol Sin (2017) 0.75
Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension. J Am Heart Assoc (2017) 0.75
Altered oscillation of Doppler-derived renal and renal interlobar venous flow velocities in hypertensive and diabetic patients. J Med Ultrason (2001) (2017) 0.75
Triple-combination therapy in the treatment of hypertension: a review of the evidence. J Hum Hypertens (2017) 0.75
Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals. J Am Geriatr Soc (2016) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
The origin of the Haitian cholera outbreak strain. N Engl J Med (2010) 9.85
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Severe hypoglycemia and risks of vascular events and death. N Engl J Med (2010) 8.54
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension (2013) 5.88
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol (2012) 4.56
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension (2003) 4.19
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med (2014) 3.81
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA (2003) 3.71
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA (2004) 3.68
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med (2005) 3.44
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Systolic pressure is all that matters. Lancet (2008) 3.42
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol (2005) 3.27
Endothelial dysfunction. J Am Soc Nephrol (2004) 3.18
NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care (2008) 3.07
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int (2004) 2.96
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2003) 2.86
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82
Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry. J Hypertens (2011) 2.76
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation (2011) 2.71
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension (2005) 2.69
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol (2008) 2.63
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58